Structure and biological activities of hypochlorite oxidized zymosan

Carbohydrate Polymers

Volumn 44, Issue 4, 2001, Pages 339-349

  Ohno, N ^a   Miura, T ^a,b   Miura, N N ^a   Adachi, Y ^a   Yadomae, T ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; POLYMERIZATION;

HYPOCHLORITE OXIDIZED ZYMOSAN;

GLUCOSE;

BOVINAE;

EID: 0035314091     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0144-8617(00)00250-2     Document Type: Article

References (49)

1. Adachi Y., Ohno N., Yadomae T. Preparation and antigen specificity of an anti-(1→3)-β-D-glucan antibody. Biological and Pharmaceutical Bulletin. 17:1994;1508-1512.
2. Adachi Y., Okazaki M., Ohno N., Yadomae T. Leukocyte activation by (1→3)-β-D-glucans. Mediators of Inflammation. 6:1997;251-256.
3. Adachi Y., Miura N.N., Ohno N., Tamura H., Tanaka S., Yadomae T. Enzyme immunoassay system for estimating the ultrastructure of (1→6) branched (1→3)-β-glucans. Carbohydrate Polymers. 39:1999;225-229.
4. Allen L.H., Aderem A. A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages. Journal of Experimental Medicine. 182:1995;829-840.
5. Ambrosino D.M., Bolon D., Collard H., Van Etten R., Kanchana M.V., Finberg R.W. Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages. Journal of Immunology. 149:1992;3978-3983.
6. Au B.T., Williams T.J., Collins P.D. Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator. Journal of Immunology. 152:1994;5411-5419.
7. Deslandes Y., Marchessault R.H., Sarko A. Triple-helical structure of (1→3)-β-D-glucan. Macromolecules. 13:1980;1466-1471.
8. DiCarlo F., Fiore J.V. On the composition of zymosan. Science. 127:1958;756-757.
9. Fogelmark B., Sjostrand M., Williams D., Rylander R. Inhalation toxicity of (1→3)-β-D-glucan: recent advances. Mediators of Inflammation. 6-4:1997;263-266.
10. Hamuro J., Chihara G. Lentinan, a T-cell-oriented immunopotentiator - its experimental and clinical applications and possible mechanism of immune modulation. Fenichel R.L., Chirigos M.A. Immune modulation agents and their mechanisms. 1984;409-435 Marcel Dekker, New York.
11. Hong K., Kinoshita T., Pramoonjago P., Kim Y.U., Seya T. Reconstitution of C5 convertase of the alternative complement pathway with isolated C3b dimer and factors B and D. Journal of Immunology. 146:1991;1868-1873.
12. Iino K., Ohno N., Suzuki I., Miyazaki T., Yadomae T., Oikawa S., Sato K. Structural characterization of a neutral antitumor beta-D-glucan extracted with hot sodium hydroxide from cultured fruit bodies of Grifola frondosa. Carbohydrate Research. 141:1985;111-119.
13. Ishioka G.Y., Lamont A.G., Thomson D., Bulbow N., Gaeta F.C., Sette A., Grey H.M. MHC interaction and T cell recognition of carbohydrates and glycopeptides. Journal of Immunology. 148:1992;2446-2451.
14. Janusz M.J., Austen K.F., Czop J.K. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles. Journal of Immunology. 142:1989;959-965.
15. 2. Journal of Immunology. 159:1997;2468-2475.
16. Kollar R., Reinhold B.B., Petrakova E., Yeh H.J.C., Ashwell G., Drgonova J., Kapteyn J.C., Klis F.M., Cabib E. Architecture of the yeast cell wall: β(1→6)-glucan interconnects mannoprotein, β(1→3)-glucan, and chitin. Journal of Biological Chemistry. 272:1997;17762-17775.
17. Kusner D.J., Hall C.F., Schlesinger L.S. Activation of phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages. Journal of Experimental Medicine. 184:1996;585-595.
18. Lu J.H., Thiel S., Wiedemann H., Timpl R., Reid K.B. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. Journal of Immunology. 144:1990;2287-2294.
19. Lundy S.R., Dowling R.L., Stevens T.M., Kerr J.S., Mackin W.M., Gans K.R. Kinetics of phospholipase A2, arachidonic acid, and eicosanoid appearance in mouse zymosan peritonitis. Journal of Immunology. 144:1990;2671-2677.
20. Miura N.N., Ohno N., Adachi Y., Aketagawa J., Tamura H., Tanaka S., Yadomae T. Comparison of clearance rate from blood stream of triple- and single-helical schizophyllan in mice. Biological and Pharmaceutical Bulletin. 18:1995;185-189.
21. Miura T., Ohno N., Suda M., Miura N.N., Shimada S., Yadomae T. Inactivation of (1→3)-β-D-glucan in mice. Biological and Pharmaceutical Bulletin. 18:1995;1797-1801.
22. Miura N.N., Ohno N., Adachi Y., Yadomae T. Characterization of sodium hypochlorite degradation of β-glucan in relation to its metabolism in vivo. Chemical and Pharmaceutical Bulletin. 44:(11):1996;2137-2141.
23. Miura N.N., Ohno N., Aketagawa J., Tamura H., Tanaka S., Yadomae T. Blood clearance of (1→3)-β-D-glucan in MRL lpr/lpr mice. FEMS Immunology and Medical Microbiology. 13:1996;51-57.
24. Miura N.N., Miura T., Ohno N., Adachi Y., Watanabe M., Tamura H., Tanaka S., Yadomae T. Gradual solubitization of Candida cell wall β-glucan by oxidative degradation in mice. FEMS Immunology and Medical Microbiology. 21:1998;123-129.
25. Miura T., Ohno N., Miura N.N., Adachi Y., Shimada S., Yadomae T. Antigen specific response of murine immune system toward a yeast β-glucan preparation, zymosan, FEMS Immunology and Medical Microbiology. 24:1999;131-139.
26. Nono I., Ohno N., Masuda A., Oikawa S., Yadomae T. Oxidative degradation of an antitumor (1→3)-β-D-glucan, grifolan. Journal of Pharmacobio-Dynamics. 14:1991;9-19.
27. Ohno N., Suzuki I., Oikawa S., Sato K., Miyazaki T., Yadomae T. Antitumor activity and structural characterization of glucans extracted from cultured fruit bodies of Grifola frondosa. Chemical and Pharmaceutical Bulletin. 32:1984;1142-1151.
28. Ohno N., Miura N.N., Chiba N., Adachi Y., Yadomae T. Comparison of the immunopharmacological activities of triple and single-helical schizophyllan in mice. Biological and Pharmaceutical Bulletin. 18:1995;1242-1247.
29. Ohno N., Hashimoto T., Adachi Y., Yadomae T. Conformation dependency of nitric oxide synthesis of murine peritoneal macrophages by β-glucans in vitro. Immunology Letters. 52:1996;1-7.
30. Ohno N., Miura T., Miura N.N., Chiba N., Uchiyama M., Adachi Y., Yadomae T. Inflammatory and immunopharmacological activities of meta-periodate oxidized zymosan. Zentralblatt fuer Bakteriologie. 289:1998;63-77.
31. Ohno N., Uchiyama M., Tsuzuki A., Tokunaka K., Miura N.N., Adachi Y., Aizawa M.W., Tamura H., Tanaka S., Yadomae T. Solubilization of yeast cell-wall β-(1→3)-D-glucan by sodium hypochlorite oxidation and dimethylsulfoxide extraction. Carbohydrate Research. 316:1999;161-172.
32. Okamura K., Suzuki M., Chihara T. Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. Cancer. 58:1986;865-872.
33. Okazaki M., Chiba N., Adachi Y., Ohno N., Yadomae T. Signal transduction pathway on β-glucans-triggered hydrogen peroxide production by murine peritoneal macrophages, in vitro. Biological and Pharmaceutical Bulletin. 19:1996;18-23.
34. Pangburn M.K. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides. Journal of Immunology. 142:1989;2759-2765.
35. 6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skin. Journal of Immunology. 159:1997;383-390.
36. Sahu A., Isaacs S.N., Soulika A.M., Lambris J.D. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. Journal of Immunology. 160:1998;5596-5604.
37. Saito H., Tabeta R., Yoshioka Y., Hara C., Kiho T., Ukai S. A high-resolution solid-state 13C NMR study of the secondary structure of branched (1→3)-β-D-glucans from fungi: evidence of two kinds of conformers, curdlan-type single-helix and laminaran-type triple-helix forms, as manifested from the conformation-dependent 13C chemical shifts. Bulletin of the Chemical Society of Japan. 60:1987;4267-4272.
38. Saito H., Yoshioka Y., Yokoi M., Yamada J. Distinct gelation mechanism between linear and branched (1→3)-beta-D-glucans as revealed by high resolution solid state 13C NMR. Biopolymers. 29:1990;1689-1698.
39. Saito K., Nishijima M., Ohno N., Nagi N., Yadomae T., Miyazaki T. Activation of complement and limulus coagulation systems by an alkali-soluble glucan isolated from Omphalia lapidescens and its less-branched derivativea. (Studies on a fungal polysaccharide. XXXIX). Chemical and Pharmaceutical Bulletin. 40:1992;1227-1230.
40. Sanguedolce M.V., Capo C., Bongrand P., Mege J.L. Zymosan-stimulated tumor necrosis factor-alpha production by human monocytes. Down-modulation by phorbol ester. Journal of Immunology. 148:1992;2229-2236.
41. Sanguedolce M.V., Capo C., Bouhamdan M., Bongrand P., Huang C.K., Mege J.L. Zymosan-induced tyrosine phosphorylations in human monocytes. Role of protein kinase C. Journal of Immunology. 151:1993;405-414.
42. Seppala I., Makela O. Antigenicity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling. Journal of Immunology. 143:1989;1259-1264.
43. Sergeant S., McPhail L.C. Opsonized zymosan stimulates the redistribution of protein kinase C isoforms in human neutrophils. Journal of Immunology. 159:1997;2877-2885.
44. Steadman R., Petersen M.M., Topley N., Williams D., Matthews N., Spur B., Williams J.D. Differential augmentation by recombinant human tumor necrosis factor-alpha of neutrophil responses to particulate zymosan and glucan. Journal of Immunology. 144:1990;2712-2718.
45. Suzuki T., Ohno N., Saito K., Yadomae T. Activation of the complement system by (1→3)-β-D-glucans having different degrees of branching and different ultrastructures. Journal of Pharmacobio-Dynamics. 15:1992;227-285.
46. Suzuki T., Ohno N., Chiba N., Miura N.N., Adachi Y., Yadomae T. Immunopharamcological activity of the purified insoluble glucan, zymocel, in mice. Journal of Pharmacy and Pharmacology. 48:1996;1243-1248.
47. Veras P.S., de Chastellier C., Rabinovitch M. Transfer of zymosan (yeast cell walls) to the parasitophorous vacuoles of macrophages infected with Leishmania amazonensis. Journal of Experimental Medicine. 176:1992;639-646.
48. Yadomae T., Ohno N. Structure-activity relationship of immunomodulating (1→3)-β-D-glucans. Recent Research and Development in Chemical and Pharmaceutical Sciences. 1:1996;23-33.
49. Zaffran Y., Escallier J.C., Ruta S., Capo C., Mege J.L. Zymosan-triggered association of tyrosine phosphoproteins and lyn kinase with cytoskeleton in human monocytes. Journal of Immunology. 154:1995;3488-3497.